Here’s a list of key deals reported across sectors this week:
- Merck (MRK) is in talks to purchase Revolution Medicines (RVMD) for about $30 billion.
- Glencore (GLCNF) (GLNCY) +9.4% in London trading Friday to its highest in more than a year following news it is in talks with Rio Tinto (RIO) about a potential merger that would create the world’s largest mining company, valued at more than $200B; Rio -4% in early U.S. trading.
- Snowflake (SNOW) is acquiring Observe to deliver AI-powered observability at enterprise scale for an undisclosed amount.
- CrowdStrike (CRWD) on Thursday announced a deal to acquire privately held AI startup SGNL in an effort to boost its artificial intelligence capabilities and strengthen its identity security lineup.
- Coincheck Group (CNCK) on Thursday announced a stock purchase agreement with its majority shareholder, Monex Group, to acquire ~97% beneficial ownership of 3iQ.
- Eli Lilly (LLY) confirmed it agreed to buy Ventyx Biosciences (VTYX) for $14 a share in cash. The deal has an aggregate equity value of about $1.2 billion, according to a statement on Wednesday.
- Marvell Technology (MRVL) is going to acquire San Jose, California-based XConn Technologies in a deal worth about $540M to bolster its AI data center connectivity solutions.
- Steel Dynamics (STLD) and Australian industrial conglomerate SGH confirmed Tuesday they are partnering on an A$13.2 billion (US$8.8 billion) bid to acquire BlueScope Steel (BLSFF) (BLSFY), Australia’s largest steel producer.
- Vistra (VST) +4.9% post-market Monday after saying it agreed to acquire Cogentrix Energy from Quantum Capital Group in a deal valued at ~$4 billion.